Stay updated on Nebulized Fentanyl in ILD Patients Clinical Trial
Sign up to get notified when there's something new on the Nebulized Fentanyl in ILD Patients Clinical Trial page.

Latest updates to the Nebulized Fentanyl in ILD Patients Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check28 days agoChange DetectedThe web page has been updated to version 2.16.0, indicating a new revision. The previous version, 2.15.2, has been removed.SummaryDifference0.3%
- Check43 days agoChange DetectedThe page has removed references to Kingston Health Sciences Centre and added information about Queen's University.SummaryDifference0.6%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to Nebulized Fentanyl in ILD Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nebulized Fentanyl in ILD Patients Clinical Trial page.